Study of the Impact of Indacaterol (Onbrez®) on the Individual Lives and Health Status of Patients With COPD
NCT02123199 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 103
Last updated 2014-04-25
Summary
A prospective observational multi centre research study in GP practices clustered within up to 10 UK Primary care trusts.
Conditions
- Chronic Obstructive Pulmonary Disease
Interventions
- DRUG
-
Indacaterol (Onbrez®) /QAB149
Sponsors & Collaborators
-
Novartis Pharmaceuticals
lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2013-12-31
Countries
- United Kingdom
Study Locations
Related Clinical Trials
-
To Determine the Relationship Between Baseline Reversibility and the Efficacy of Indacaterol
NCT01272362 · Status: COMPLETED · Phase: PHASE4
- Chronic Obstructive Pulmonary Disease (COPD)
-
12-week Open-label Evaluation of Efficacy and Safety of Indacaterol
NCT01232894 · Status: COMPLETED · Phase: PHASE3
- Chronic Obstructive Pulmonary Disease (COPD)
-
Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPD
NCT02059434 · Status: COMPLETED · Phase: PHASE1
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma
-
Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.)
NCT01555138 · Status: COMPLETED · Phase: PHASE4
- Chronic Obstructive Pulmonary Disease
-
Indacaterol 75 μg Compared to Placebo, Assessing Time to Patient's Perception of Onset of Effect in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT01543828 · Status: COMPLETED · Phase: PHASE4
- COPD
More Related Trials
-
The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT00620022 ·Status: COMPLETED ·Phase: PHASE3
-
Indacaterol EfectIveness In COPD Patients With Tuberculosis History
NCT01778062 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients
NCT01921712 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00615030 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Indacaterol in Symptomatic COPD Patients With Low Risk of Exacerbations
NCT02418468 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT00669617 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Indacaterol on Inspiratory Capacity and Lung Function in Patients With COPD Versus Placebo and Formoterol
NCT00422552 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Asthma Bronchial Challenge Study
NCT03575663 ·Status: COMPLETED
-
Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)
NCT01721291 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Safety and Tolerability of the Co-administration of NVA237 Plus Indacaterol Once Daily Versus Indacaterol Once Daily in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT01604278 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00624286 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of DNK333 in Patients With COPD and Cough
NCT01287325 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Inhaled Bronchodilator Association and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease
NCT02176564 ·Status: COMPLETED
-
A Phase II, 5-way Cross-over Study to Evaluate the Pharmacodynamics of "Nexthaler" Dry Powder Inhaler in COPD Patients
NCT02000609 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment and Exacerbation in COPD Subjects
NCT03375450 ·Status: COMPLETED
-
Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks
NCT01068600 ·Status: COMPLETED ·Phase: PHASE3
-
Swiss studY for the Treatment of COPD Patients With the Free combiNation of indacatERol and GlYcopyrroniumbromide.
NCT01699685 ·Status: COMPLETED ·Phase: PHASE3
-
Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.
NCT00430300 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary Disease
NCT06434792 ·Status: RECRUITING ·Phase: PHASE2
-
A Crossover Study to Determine the 24 Hour Lung Function Profile of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
NCT00622635 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control
NCT00567996 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)
NCT01089127 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00570778 ·Status: COMPLETED ·Phase: PHASE2
-
An Exploratory Study, to Assess the Effect of Repeat-dose Inhaled Indacaterol Maleate (300 μg) on Dynamic and Static Lung Hyperinflation, Subjective Breathlessness and Health Status in Patients With Chronic Obstructive Pulmonary Disease(COPD)
NCT00636961 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) on Cardiac Function in COPD Patients
NCT02442206 ·Status: COMPLETED ·Phase: PHASE4